% Cost of sales - 191.6 - 160.8 -19.1% Selling expenses - 4.7 - 4.0 -17.8% Administrative expenses - 10.1 - 11.9 15.5% Finance costs - 2.8 - 3.0 5.3% Profit for the period 12.7 20.6 -38.5% Net Profit 5.7
3122.1% Cost of sales - 151.2 - 216.3 30.1% Selling expenses - 5.3 - 5.4 2.7% Administrative expenses - 9.6 - 10.7 10.8% Finance costs - 3.1 - 2.8 -9.7% Profit for the period 17.2 5.3 222.9% Net Profit 9.1
48.4 (525.6) (24.6) Selling expenses 505.1 12.1 514.6 15.4 9.5 1.9 Administrative expenses 94.4 2.3 132.6 4.0 38.2 40.5 Total Expenses 2,738.8 65.5 2,260.9 67.8 (477.9) (17.4) Profit before share of loss
status for the Q2/2020 ended June 30, 2020 of the Company and its subsidiaries, as shown below: (Unit : Thousand Baht) Q2/2020 Q2/2019 Change %Change Revenue 255,560 229,355 26,205 11.43% Gross profit
; including operate clinical business which dialysis services for kidney patients who receive replacement therapy with dialysis by dialysis machinery (Dialysis Center) and distribution of medical equipment as
Discussion & Analysis Q2/2021 Operating Highlights in Q2/2021 Q2/20 Q2/21 Change +/(-) 1H/20 1H/21 Change +/(-) (THB million) %YoY %YoY Operating Revenue 144 137 (5%) 363 317 (13%) Gross Profit 79 77 (3%) 216
comparison million or net profit o Summary The Operatin venues : Revenues from services Other income Total rev penses : Cost of sales an Administrative expenses Total ex are of profit o associated com nance
% Administrative expenses 25.60 30.62 -5.02 -16.40% Reversal of doubtful debts -3.34 - -3.34 100.00% Total expenses 230.04 108.41 121.63 112.19% Profit before finance costs and income tax expenses -1.35 9.69 - 11.03
performance in the second quarter shows total revenue of 16,464.72 million Baht, whilst net profit stood at 1,312.56 million Baht; this represents growth of 4.38% and 16.03% respectively compared to the same
% Gross Profit 40.35 60.30 -19.95 -33.08% 95.98 169.48 -73.50 -43.37% Other Income 79.28 16.06 63.22 393.52% 88.89 30.93 57.96 187.38% Selling & Administrative Expenses 31.98 39.27 -7.29 -18.57% 65.31 78.98